Security key
00973N102
Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (AKTSQ)
CUSIP: 00973N102
Q2 2019 13F Holders as of 30 Jun 2019
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 11,160,282
- Total 13F value
- $71,421,311
- Share change
- +4,395,006
- SEC-reported price per share
- $6.40
- Number of holders
- 74
- Value change
- +$28,509,937
- Number of buys
- 47
- Number of sells
- 22
- Shares outstanding
- 53,401,149
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
74
Top holders
10
AKTSQ full security history
Ownership snapshot
Full 13F holder table
Aktis Oncology, Inc. SEC filings
Aktis Oncology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AKTSQ - Aktis Oncology, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Mar 2019
13F
Highest disclosed value: $6,264,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $6.26M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
VANGUARD GROUP INC
$6.26M
SILVERBACK ASSET MANAGEMENT LLC
$4.7M
HERALD INVESTMENT MANAGEMENT Ltd
$3.36M
NORTH RUN CAPITAL, LP
$1.8M
First Eagle Investment Management...
$1.77M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$6,264,000
1,078,218 shares
|
— | 31 Mar 2019 |
| SILVERBACK ASSET MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$4,701,000
809,056 shares
|
— | 31 Mar 2019 |
| HERALD INVESTMENT MANAGEMENT Ltd |
13F
Company
|
—
denominator unverified
|
$3,361,000
578,636 shares
|
— | 31 Mar 2019 |
| NORTH RUN CAPITAL, LP |
13F
Company
|
—
denominator unverified
|
$1,801,000
310,000 shares
|
— | 31 Mar 2019 |
| First Eagle Investment Management, LLC |
13F
Company
|
—
denominator unverified
|
$1,769,000
304,490 shares
|
— | 31 Mar 2019 |
| MISSION WEALTH MANAGEMENT, LP |
13F
Company
|
—
denominator unverified
|
$1,627,000
279,987 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
74
Shares
11,160,282
Rows available
74
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
61
Q2 2019 holders
74
Holder diff
13
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|